Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A malignant neoplasm involving the gall bladder
Biomarker and diagnostic research for gallbladder cancer has been reported in the published literature.
60 clinical trials registered, 28 recruiting. Interventions under study include drug therapy, other interventions, procedural interventions, and biologic therapy. Pipeline includes 1 PHASE3, 25 PHASE2, 9 PHASE1. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06852287](https://clinicaltrials.gov/study/NCT06852287) |
Data assembled from 3 of 12 sources · Last updated Nov 3, 2026, 6:00 AM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer |
PHASE2 |
Tianjin Medical University Cancer Institute and Hospital |
RECRUITING |
[NCT06101277](https://clinicaltrials.gov/study/NCT06101277) | Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) | NA | University of California, Davis | RECRUITING |
[NCT06123117](https://clinicaltrials.gov/study/NCT06123117) | STALL vs Sole Local Wound Infiltration in Laparoscopic Cholecystectomy | NA | Helsinki University Central Hospital | RECRUITING |
[NCT06423170](https://clinicaltrials.gov/study/NCT06423170) | A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCs | PHASE2 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | RECRUITING |
[NCT03637569](https://clinicaltrials.gov/study/NCT03637569) | The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer | — | Samsung Medical Center | RECRUITING |
283 publications have been identified in PubMed for gallbladder cancer. Research spans Basic Science / Preclinical (24%), Review / Meta-Analysis (21%), and Epidemiology / Natural History (15%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 67 | 24% |
Research summaries | 60 | 21% |
Disease patterns and progression | 42 | 15% |
Testing and diagnosis research | 34 | 12% |
Clinical study results | 34 | 12% |
Patient case studies | 27 | 10% |
New treatment approaches | 12 | 4% |
Other research | 7 | 2% |
Wylie J (2026). [PMID: 42209933](https://pubmed.ncbi.nlm.nih.gov/42209933/). *Int J Clin Oncol*. [Review / Meta-Analysis]
Das D (2026). [PMID: 41649626](https://pubmed.ncbi.nlm.nih.gov/41649626/). *J Gastrointest Cancer*. [Review / Meta-Analysis]
Jaiswar D (2026). [PMID: 42204532](https://pubmed.ncbi.nlm.nih.gov/42204532/). *Cancer Cell Int*. [Review / Meta-Analysis]
Wang H (2026). [PMID: 42065192](https://pubmed.ncbi.nlm.nih.gov/42065192/). *Medicine (Baltimore)*. [Case Report / Case Series]
Sahoo OS (2026). [PMID: 42154094](https://pubmed.ncbi.nlm.nih.gov/42154094/). *Mol Biol Rep*. [Review / Meta-Analysis]
Mellado S (2026). [PMID: 42264698](https://pubmed.ncbi.nlm.nih.gov/42264698/). *Surg Oncol Clin N Am*. [Review / Meta-Analysis]
Gárate-Calderón V (2026). [PMID: 42167123](https://pubmed.ncbi.nlm.nih.gov/42167123/). *EBioMedicine*. [Epidemiology / Natural History]
Kurdia KC (2026). [PMID: 41524978](https://pubmed.ncbi.nlm.nih.gov/41524978/). *J Gastrointest Cancer*. [Review / Meta-Analysis]
Li W (2026). [PMID: 41934482](https://pubmed.ncbi.nlm.nih.gov/41934482/). *J Cancer Res Clin Oncol*. [Basic Science / Preclinical]
Sumii R (2026). [PMID: 42183980](https://pubmed.ncbi.nlm.nih.gov/42183980/). *Clin J Gastroenterol*. [Case Report / Case Series]
AI-curated news mentioning gallbladder cancer
Updated Sep 27, 2026
A recent analysis of gallbladder cancer outcomes using the National Cancer Database (NCDB) identifies key predictors of patient survival. This study provides valuable insights that could inform treatment strategies and improve patient management.
A recent study highlights the prognostic significance of tumor budding, tumor-stroma ratio, and Annexin A1 in gallbladder cancer. These findings could inform future research and treatment strategies for this rare cancer type.
A case report highlights gallbladder cancer presenting with a single giant common bile duct stone in a patient with normal cholestatic function tests. This unique presentation may provide insights into the clinical manifestations of gallbladder cancer.